Medihoney is the first honey-based product cleared for use by Health Canada and also the first cleared for use by the FDA. These unique dressings contain Active Leptospermum Honey, indigenous to New Zealand (Manuka) and Australia (Jellybush). Medihoney provides a moist, occlusive environment conducive to optimal wound healing. Medihoney dressings have been shown to possess unique qualities that make them ideal for the management of chronic and acute wounds and burns.Because they contain a very high percentage of Leptospermum honey, Medihoney dressings are able to work in the presence of wound fluid, blood, and tissue, thus promoting an optimal healing environment. For use on: diabetic foot ulcers, venous stasis leg ulcers, arterial leg ulcers, leg ulcers of mixed etiology, pressure ulcers (I-IV), 1st and 2nd degree burns, donor sites, and traumatic and surgical wounds. Due to their versatility and lack of toxicity, Medihoney dressings can be used in all stages of wound healing, and can also be used as an important component of wound bed preparation. As such, placing these dressings as the cornerstones of a wound care formulary can take a great deal of the guess-work out of wound management. More info at DermaSciences.com. 1.5 Oz. Hydrocolloid Wound Paste, $18 from Amazon.